In the present study, we conducted a quantitative systematic evaluation, and then evaluated the effect of AFAP1‐AS1 on the clinicopathological features and prognosis of GC by using the follow‐up population, and further confirmed the results of quantitative evaluation. The gene discussed is AFAP1; the disease is gastric cancer.